Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma

BACKGROUNDS: SET and MYND domain-containing protein 2 (SMYD2), which is identified as a protein-lysine methyltransferase, plays a crucial role in the progression of some tumors such as bladder carcinoma. However, the clinical significance of SMYD2 in patients with papillary thyroid carcinoma (PTC) h...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wenchao, Chen, Fulian, Fei, Xiao, Yang, Xiaoqing, Lu, Xiaofei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198713/
https://www.ncbi.nlm.nih.gov/pubmed/30319138
http://dx.doi.org/10.12659/MSM.910168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198713/
https://www.ncbi.nlm.nih.gov/pubmed/30319138
http://dx.doi.org/10.12659/MSM.910168

Ejemplares similares